Bio-Rad Laboratories Net Tangible Assets

As of the most recent data (June 2026), BIO.B shows a net tangible assets of $7.2B. That compares with $7.1B in the prior-year period — up 0.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIO.B's net tangible assets is now $7.2B (was $7.1B) — a 0.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Rad Laboratories is outperforming or lagging.

Tracking BIO.B's net tangible assets over time shows whether Bio-Rad Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $7.2B That compares with $7.1B in the prior-year period — up 0.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Bio-Rad Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $7.2B) with ownership activity and broader fundamentals.

Bio-Rad Laboratories's net tangible assets is $7.2B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.